A. Boer

发表

Blood – Brain Barrier In Vitro Models and Their Application in Toxicology The Report and Recommendations of ECVAM Workshop

Anna Forsby, Sandra Coecke, Anna Price, 2004 .

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

O. Meijer, D. Breimer, E. D. de Kloet, 1998, Endocrinology.

Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

P J Lucassen, O. Meijer, P. Lucassen, 2001, Endocrinology.

Rate-controlled rectal drug delivery in man with a hydrogel preparation

J. Feijen, D. Breimer, A. D. Boer, 1986 .

Zero-order rectal delivery of theophylline in man with an osmotic system

D. Breimer, A. D. Boer, L. D. Leede, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man

D. Breimer, A. D. Boer, A. Boer, 1975, European Journal of Clinical Pharmacology.

Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.

H. Junginger, A. G. de Boer, A. F. Kotzé, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrier

C. Verrips, S. V. D. Maarel, S. Duinen, 2011, Neuroscience.

Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug.

P. Gaillard, A. G. de Boer, A. Boer, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The role of drug transporters at the blood-brain barrier.

P. Gaillard, A. G. de Boer, I. C. J. van der Sandt, 2003, Annual review of pharmacology and toxicology.

Liver Blood Flow as a Major Determinant of the Clearance of Recombinant Human Tissue-Type Plasminogen Activator

H. Schoemaker, D. Breimer, A. Cohen, 1992, Thrombosis and Haemostasis.

The blood-brain barrier in neuroinflammatory diseases.

D D Breimer, H. D. de Vries, T. V. van Berkel, 1997, Pharmacological reviews.

Drug absorption by sublingual and rectal routes.

D. Breimer, A. D. De Boer, L. D. de Leede, 1984, British journal of anaesthesia.

Methodological issues in microdialysis sampling for pharmacokinetic studies.

D. Breimer, E. D. de Lange, E. D. Lange, 2000, Advanced drug delivery reviews.

Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.

H. Junginger, M. Thanou, A. G. de Boer, 2000, Journal of controlled release : official journal of the Controlled Release Society.

The blood-brain barrier and drug transport to the brain

P. Gaillard, A. D. Boer, A. Boer, 2002 .

A novel opportunity for targeted drug delivery to the brain.

P. Gaillard, A. G. de Boer, A. Boer, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

C. Ringbom, D. Breimer, P. Gaillard, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport.

H. D. de Vries, T. V. van Berkel, J. Kuiper, 1995, Biochemical pharmacology.

Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrier

C. Verrips, S. Duinen, M. Maat‐Schieman, 2011, Neuroscience.

Transport of Drugs Across the Blood-Brain Barrier: In Vitro and in Vivo Strategies

D. Breimer, A. Boer, J. B. V. Bree, 1991 .

The blood-brain barrier and multiple sclerosis.

A. Moor, H. D. de Vries, D. Breimer, 1994, Biochemical pharmacology.

Rate controlled rectal drug delivery in man

D. Breimer, A. D. Boer, L. D. Leede, 1985 .

Drug targeting to the diseased brain

G. Schenk, A. D. Boer, A. Boer, 2013 .

In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.

W. Couet, E. D. de Lange, I. C. J. van der Sandt, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Blood–brain barrier dysfunction and recovery

P. Gaillard, A. G. de Boer, A. Boer, 2006, Journal of Neural Transmission.

Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers

M. Danhof, D. Breimer, A. Moolenaar, 2004, European Journal of Clinical Pharmacology.